top of page
jervis.JPG

Dr. Peter Jervis

A short peptide composed of unusual amino acids affords an injectable
supramolecular hydrogel with ultra-low critical gelation concentration

Short Abstract:

Supramolecular hydrogels are a useful class of soft material with many applications in drug delivery, tissue engineering, wound treatment, biosensors, 3D bioprinting and many others. My current research involves the use of unusual amino acids to obtain novel peptide / peptidomimetic hydrogelators with unique properties. In this talk, I will present an update on some of our recently developed supramolecular hydrogelators which are capable of forming injectable hydrogels with very low critical gelation concentrations (CGCs).

​

Short CV:

Dr. Peter John Jervis obtained his PhD in Organic Chemistry from the University of Birmingham (UK) in 2008, under the supervision of Dr. Liam Cox, working on the total synthesis of the natural products. Completed two postdoctoral positions in Birmingham, the first with Dr. Richard Grainger on organosulfur chemistry, and the second in the group of Prof. Gurdyal Besra, on a Medicinal Chemistry project developing compounds active against tuberculosis. Spent some years in industry, working for GlaxoSmithKline and then AstraZeneca on Medicinal Chemistry projects. In 2018, returned to academia with a move to Portugal, to work on collaborative project between the University of Porto (Prof. David Pereira) and the University of Minho (Prof. Paula Ferreira and Prof. José Alberto Martins), to carry out a research project on supramolecular hydrogels.

​

bottom of page